Document is current
Any future updates will be listed below
-
Authors
Stalinska, Joanna https://orcid.org/0000-0001-6040-6289
Houser, Lisa
Rak, Monika
Colley, Susan B.
Reiss, Krzysztof
Jursic, Branko S.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P20GM121288)
Louisiana State University Health Sciences Center, New Orleans LA 70112; School of Medicine; Dean Matching Funds
- License Information
-
More Information
Article History
Received: 29 August 2019
Accepted: 21 October 2019
First Online: 19 November 2019
Competing interests
: Disclosure of Potential Conflict of Interest: Dr. Branko Jursic is associated with Stepharm LLC, P.O. Box 24220, New Orleans, LA; Dr. Krzysztof Reiss and Dr. Branko Jursic have an LSU provisional patent for the HR compounds presented in this manuscript (“Anticancer Composition and methods of use” 2932719-056-us2). Other authors do not have any competing interest in relation to this submission.
